Everolimus tablets for oral suspension become the first approved therapy specifically indicated for the treatment of partial-onset seizures associated with tuberous sclerosis complex.
FDA Approvals
This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.
Leave a Reply